AU3519095A - Oligonucleotide conjugates, compositions and methods for slitting ribonucleic acids - Google Patents

Oligonucleotide conjugates, compositions and methods for slitting ribonucleic acids

Info

Publication number
AU3519095A
AU3519095A AU35190/95A AU3519095A AU3519095A AU 3519095 A AU3519095 A AU 3519095A AU 35190/95 A AU35190/95 A AU 35190/95A AU 3519095 A AU3519095 A AU 3519095A AU 3519095 A AU3519095 A AU 3519095A
Authority
AU
Australia
Prior art keywords
slitting
compositions
methods
ribonucleic acids
oligonucleotide conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35190/95A
Inventor
Jonathan Hall
Robert Haner
Dieter Husken
Heinz Moser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU3519095A publication Critical patent/AU3519095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU35190/95A 1994-09-02 1995-08-30 Oligonucleotide conjugates, compositions and methods for slitting ribonucleic acids Abandoned AU3519095A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
CH2694/94 1994-09-02
PCT/EP1995/003408 WO1996007667A1 (en) 1994-09-02 1995-08-30 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids

Publications (1)

Publication Number Publication Date
AU3519095A true AU3519095A (en) 1996-03-27

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35190/95A Abandoned AU3519095A (en) 1994-09-02 1995-08-30 Oligonucleotide conjugates, compositions and methods for slitting ribonucleic acids

Country Status (8)

Country Link
EP (1) EP0778845A1 (en)
JP (1) JPH10505353A (en)
AU (1) AU3519095A (en)
CA (1) CA2197785A1 (en)
FI (1) FI970696A0 (en)
HU (1) HUT77034A (en)
NO (1) NO970885L (en)
WO (1) WO1996007667A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
EP0920439B1 (en) * 1996-08-20 2003-04-02 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (en) * 2006-11-16 2011-06-10 주식회사 엘지화학 Purification method of terephthal aldehyde
WO2008124614A1 (en) 2007-04-06 2008-10-16 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CL2008000985A1 (en) 2007-04-06 2008-10-10 Neurocrine Biosciences Inc COMPOUND DERIVED FROM NITROGEN HETEROCICLES, GNRH RECEIVER AGONISTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE TO TREAT AN AFFECTION RELATED TO SEX HORMONES, ENDOMETRIOSIS, DISMENORREA, OV DISEASE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
HUT77034A (en) 1998-03-02
FI970696A (en) 1997-02-19
EP0778845A1 (en) 1997-06-18
NO970885D0 (en) 1997-02-27
NO970885L (en) 1997-04-25
JPH10505353A (en) 1998-05-26
WO1996007667A1 (en) 1996-03-14
FI970696A0 (en) 1997-02-19
CA2197785A1 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
AU7120698A (en) Biodegradable compounds, compositions, articles and methods for making and usingthe same
AU4802896A (en) Phosphonomonoester nucleic acids, process for their preparation, and their use
EP1002559B8 (en) Gun-shaped controller
AU4728899A (en) Method for preparing oligonucleotides with boranophosphate linkages
EP0710667B8 (en) Modified oligonucleotides, their preparation and their use
AU1119399A (en) Microorganism genomics, compositions and methods related thereto
AU1581895A (en) Nucleic acid-containing composition, its preparation and use
EP0690039A3 (en) Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
AU2449995A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
AU2310795A (en) Novel erythromycin derivatives, method for preparing same and use thereof as drugs
AU7549298A (en) Method for administering viable microorganism composition for poultry
AU2215995A (en) Freeze-dried compositions comprising rna
EP1072266B8 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
AU1646599A (en) Microorganism, method for obtaining same and feed additive
AU3340797A (en) Modified oligonucleotides
AU7918398A (en) Oligonucleotide derivatives
AU3519095A (en) Oligonucleotide conjugates, compositions and methods for slitting ribonucleic acids
AU3772795A (en) Polyol composition, process for its preparation and its applications
AU5178999A (en) Nucleic acid delivery
AU2792195A (en) Chondramides, production methods, compositions comprising chondramides and cultures for chondramide production
AU2268099A (en) Dendritic polymer-saccharide conjugate, pharmaceuticals containing said conjugate, method for its production and use thereof
AU3820699A (en) Catalyst and process for its preparation
AU7675198A (en) Sucralfate-containing composition and process for the preparation thereof
AU2842195A (en) Connector, in particular singel-entry connector
ZA967817B (en) Phenylacetic acids, their preparation, and compositions comprising them.